Literature DB >> 8375811

The economic burden of Alzheimer's disease care.

D P Rice1, P J Fox, W Max, P A Webber, D A Lindeman, W W Hauck, E Segura.   

Abstract

This study examines total formal and informal care costs attributable to Alzheimer's disease for persons living in the community and in institutions. The total cost of caring for an Alzheimer's patient in northern California is approximately $47,000 per year whether the patient lives at home or in a nursing home, but the cost breakdown differs in the two settings. For community-resident patients, three-fourths of the total cost represents an imputed value for unpaid informal care compared with 12 percent for institutionalized patients. Formal services are financed primarily by individuals and their families. Over 60 percent of the services provided to patients in either care setting were paid out of pocket. With projected increases in the number of persons at risk of developing Alzheimer's disease, the economic impact of the disease on future long-term care costs will be significant.

Entities:  

Mesh:

Year:  1993        PMID: 8375811     DOI: 10.1377/hlthaff.12.2.164

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  59 in total

1.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 2.  Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials.

Authors:  C Pimouguet; T Lavaud; J F Dartigues; C Helmer
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

Review 3.  Alzheimer's disease: the strength of association of costs with different measures of disease severity.

Authors:  J Mauskopf; J Racketa; E Sherrill
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

4.  Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries.

Authors:  Jaime Caro; Maribel Salas; Alexandra Ward; Denis Getsios; Kristen Migliaccio-Walle; Frances Garfield
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Population aging and the need for long term care: a comparison of the United States and the People's Republic of China.

Authors:  P Arnsberger; P Fox; X Zhang; S Gui
Journal:  J Cross Cult Gerontol       Date:  2000

Review 6.  Mild cognitive impairment in older adults.

Authors:  Yonas E Geda
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

Review 7.  Family involvement in residential long-term care: a synthesis and critical review.

Authors:  J E Gaugler
Journal:  Aging Ment Health       Date:  2005-03       Impact factor: 3.658

8.  Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease.

Authors:  Stefan J Teipel; Michael Ewers; Veronika Reisig; Bernd Schweikert; Harald Hampel; Michael Happich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-01       Impact factor: 5.270

9.  Collaborative care management reduces disparities in dementia care quality for caregivers with less education.

Authors:  Arleen F Brown; Stefanie D Vassar; Karen I Connor; Barbara G Vickrey
Journal:  J Am Geriatr Soc       Date:  2013-01-15       Impact factor: 5.562

10.  Causes of syncope in patients with Alzheimer's disease treated with donepezil.

Authors:  Philippe Bordier; Stephane Lanusse; Stephane Garrigue; Charlotte Reynard; Frederic Robert; Laurent Gencel; Alexia Lafitte
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.